A new Weight Loss injection that has the potential to cut the risk of diabetes by 50% is being hailed as the biggest game changer yet. It makes the first attempt to treat obesity as an illness. According to a research from the University of Alabama, participants who received weekly semaglutide injections and were overweight or obese lost an average of 37 pounds as a result.
Dr. Timothy Garvey, the lead author of the study said that they have not observed this degree of Weight Loss with any prior drug. More over 60% of trial participants lose 19% of their body weight, and ranging from a third to 50% of patients lose 10% of their body weight.
Despite the fact that the mixture was designed with diabetes in mind, the study’s authors discovered it was also effective against cardiovascular disease, as well as its associated comorbidities including osteoarthritis and sleep apnea. The lesser dosage of 1 milligramme of semaglutide, sold under the trade name Ozempic, was initially approved by the Food and Drug Administration. It had a monthly payment at the time of about $1,627 before insurance.